Form 8-K - Current report:
SEC Accession No. 0000950170-25-029040
Filing Date
2025-02-27
Accepted
2025-02-27 16:10:40
Documents
14
Period of Report
2025-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20250227.htm   iXBRL 8-K 47140
2 EX-99.1 crnx-ex99_1.htm EX-99.1 162506
3 GRAPHIC img113038668_0.jpg GRAPHIC 19545
4 GRAPHIC img113038668_1.jpg GRAPHIC 19545
  Complete submission text file 0000950170-25-029040.txt   387271

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20250227.xsd EX-101.SCH 23893
16 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20250227_htm.xml XML 4534
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 25678824
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)